Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-05-28
DOI
10.3389/fmicb.2019.01186
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Strain-specific antibody therapy prevents cytomegalovirus reactivation after transplantation
- (2019) Jose Paulo Martins et al. SCIENCE
- In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation
- (2019) Jochen J Frietsch et al. Mediterranean Journal of Hematology and Infectious Diseases
- Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis
- (2019) Mohamed Zuhair et al. REVIEWS IN MEDICAL VIROLOGY
- Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation
- (2019) Pavankumar Reddy Varanasi et al. PLoS One
- Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance
- (2019) Jocelyne Piret et al. ANTIVIRAL RESEARCH
- Adjuvant Peptide Pulsed Dendritic Cell Vaccination in Addition to T Cell Adoptive Immunotherapy for Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
- (2018) Chun K.K. Ma et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Early human cytomegalovirus reactivation is associated with lower incidence of relapse of myeloproliferative disorders after allogeneic hematopoietic stem cell transplantation
- (2018) Zinaida Peric et al. BONE MARROW TRANSPLANTATION
- Validation of a plasma metabolomics model that allows anticipation of the occurrence of cytomegalovirus DNAaemia in allogeneic stem cell transplant recipients
- (2018) Daniel Monleón et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors
- (2018) Etienne Patin et al. NATURE IMMUNOLOGY
- Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells
- (2018) Quirin Hammer et al. NATURE IMMUNOLOGY
- The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation
- (2018) Brandon J. Webb et al. Transplant Infectious Disease
- Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing
- (2018) Miri Shnayder et al. mBio
- Human cytomegalovirus reprogrammes haematopoietic progenitor cells into immunosuppressive monocytes to achieve latency
- (2018) Dihan Zhu et al. Nature Microbiology
- Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials
- (2018) Roy F Chemaly et al. CLINICAL INFECTIOUS DISEASES
- Tumor Necrosis Factor Alpha Induces Reactivation of Human Cytomegalovirus Independently of Myeloid Cell Differentiation following Posttranscriptional Establishment of Latency
- (2018) Eleonora Forte et al. mBio
- Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution
- (2018) Ricardo Melendez-Munoz et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Deep functional immunophenotyping predicts risk of cytomegalovirus reactivation after hematopoietic cell transplantation
- (2018) Jose F. Camargo et al. BLOOD
- Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis
- (2018) Bettina M. Knoll et al. BONE MARROW TRANSPLANTATION
- Cytomegalovirus Exposure in the Elderly Does Not Reduce CD8 T Cell Repertoire Diversity
- (2018) Paul Lindau et al. JOURNAL OF IMMUNOLOGY
- Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation
- (2017) Rick Admiraal et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection
- (2017) Claire L. Gordon et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The impact of virus population diversity on the dynamics of cytomegalovirus DNAemia in allogeneic stem cell transplant recipients
- (2017) Víctor Vinuesa et al. JOURNAL OF GENERAL VIROLOGY
- Modulation of the Host Environment by Human Cytomegalovirus with Viral Interleukin 10 in Peripheral Blood
- (2017) Vivian P. Young et al. JOURNAL OF INFECTIOUS DISEASES
- Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation
- (2017) Michelle K. Yong et al. JOURNAL OF INFECTIOUS DISEASES
- Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT
- (2017) M Neuenhahn et al. LEUKEMIA
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
- (2017) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity
- (2017) Charles E. Hall et al. PLoS One
- Functional specific-T-cell expansion after first cytomegalovirus reactivation predicts viremia control in allogeneic hematopoietic stem cell transplant recipients
- (2017) Miriam Ciáurriz et al. Transplant Infectious Disease
- Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein
- (2017) B. A. Krishna et al. Nature Communications
- Mass Cytometry and Topological Data Analysis Reveal Immune Parameters Associated with Complications after Allogeneic Stem Cell Transplantation
- (2017) Tadepally Lakshmikanth et al. Cell Reports
- Establishing the Optimal Viral Load Threshold for Initiation of Therapy for Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Recipients: A Prospective Derivation Cohort Study Using the International Standardized CMV Quantitative Nucleic Acid Testing
- (2017) Zachary Hanna et al. Open Forum Infectious Diseases
- Multiplex real-time PCR to identify a possible reinfection with different strains of human cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients
- (2016) Barbara Zawilinska et al. ACTA BIOCHIMICA POLONICA
- Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
- (2016) P. Teira et al. BLOOD
- How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients
- (2016) F. El Chaer et al. BLOOD
- Impact of early CMV reactivation in cord blood stem cell recipients in the current era
- (2016) M Ramanathan et al. BONE MARROW TRANSPLANTATION
- Immune recovery and the risk of CMV/ EBV reactivation in children post allogeneic haematopoietic stem cell transplantation
- (2016) Małgorzata Janeczko et al. Central European Journal of Immunology
- Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8+T cell receptor alpha repertoire following allogeneic transplantation
- (2016) C. S. Link et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status
- (2016) S. Servais et al. CLINICAL MICROBIOLOGY AND INFECTION
- Appearance of cytomegalovirus-specific T-cells predicts fast resolution of viremia post hematopoietic stem cell transplantation
- (2016) Ondřej Pelák et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide
- (2016) Scott R. Goldsmith et al. HAEMATOLOGICA
- Poor CMV-specific CD8+ T central memory subset recovery at early stage post-HSCT associates with refractory and recurrent CMV reactivation
- (2016) Jing Liu et al. JOURNAL OF INFECTION
- Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation
- (2016) Julia Drylewicz et al. Journal of Translational Medicine
- Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art
- (2016) Ana Bela Campos et al. REVIEWS IN MEDICAL VIROLOGY
- Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation
- (2016) Michael Slade et al. Transplant Infectious Disease
- Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide
- (2016) Scott R. Goldsmith et al. HAEMATOLOGICA
- Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study
- (2016) Margaret L Green et al. Lancet Haematology
- Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients
- (2016) David Navarro et al. Open Forum Infectious Diseases
- Transient activation of human cytomegalovirus lytic gene expression during latency allows cytotoxic T cell killing of latently infected cells
- (2016) B. A. Krishna et al. Scientific Reports
- In VitroDrug Combination Studies of Letermovir (AIC246, MK-8228) with Approved Anti-Human Cytomegalovirus (HCMV) and Anti-HIV Compounds in Inhibition of HCMV and HIV Replication
- (2015) Steffen Wildum et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reconstitution of Human Cytomegalovirus–Specific CD4 + T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection
- (2015) Elisa Gabanti et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Incidence, Risk Factors, and Outcome of Cytomegalovirus Viremia and Gastroenteritis in Patients with Gastrointestinal Graft-versus-Host Disease
- (2015) Divaya Bhutani et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group
- (2015) Katsuto Takenaka et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Adaptive Natural Killer Cell and Killer Cell Immunoglobulin–Like Receptor–Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation
- (2015) Zachary B. Davis et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells
- (2015) Laurie Menger et al. BLOOD
- CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire
- (2015) Yvonne Suessmuth et al. BLOOD
- Variation in the Human Immune System Is Largely Driven by Non-Heritable Influences
- (2015) Petter Brodin et al. CELL
- Reduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation Practices
- (2015) Veronique Erard et al. CLINICAL INFECTIOUS DISEASES
- Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality
- (2015) J. Liu et al. CLINICAL MICROBIOLOGY AND INFECTION
- Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing +T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies
- (2015) L. Muccio et al. HAEMATOLOGICA
- Commutability of the First World Health Organization International Standard for Human Cytomegalovirus
- (2015) R. T. Hayden et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Cytomegalovirus load at treatment initiation is predictive of time to resolution of viremia and duration of therapy in hematopoietic cell transplant recipients
- (2015) Susanna K. Tan et al. JOURNAL OF CLINICAL VIROLOGY
- Role of cytomegalovirus (CMV)-specific polyfunctional CD8+ T-cells and antibodies neutralizing virus epithelial infection in the control of CMV infection in an allogeneic stem-cell transplantation setting
- (2015) Estela Giménez et al. JOURNAL OF GENERAL VIROLOGY
- Characterization of Cytomegalovirus Breakthrough Events in a Phase 2 Prophylaxis Trial of Letermovir (AIC246, MK 8228)
- (2015) Peter Lischka et al. JOURNAL OF INFECTIOUS DISEASES
- CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT
- (2015) F Cichocki et al. LEUKEMIA
- Risk factors and prognostic scale for cytomegalovirus (CMV) infection in CMV-seropositive patients after allogeneic hematopoietic cell transplantation
- (2015) L. Cohen et al. Transplant Infectious Disease
- Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis
- (2015) R. Crocchiolo et al. Transplant Infectious Disease
- Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing +T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies
- (2015) L. Muccio et al. HAEMATOLOGICA
- Alveolar Macrophages Isolated Directly From Human Cytomegalovirus (HCMV)–Seropositive Individuals Are Sites of HCMV Reactivation In Vivo
- (2015) Emma Poole et al. JOURNAL OF INFECTIOUS DISEASES
- Perivascular Stromal Cells as a Potential Reservoir of Human Cytomegalovirus
- (2014) M. A. Soland et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen–Matched Unrelated and Related Donors
- (2014) Antonio Di Stasi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impact of Cytomegalovirus Replication and Cytomegalovirus Serostatus on the Outcome of Patients with B Cell Lymphoma after Allogeneic Stem Cell Transplantation
- (2014) Jacopo Mariotti et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Early Cytomegalovirus Reactivation Leaves a Specific and Dynamic Imprint on the Reconstituting T Cell Compartment Long-Term after Hematopoietic Stem Cell Transplantation
- (2014) Gertjan Lugthart et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Post transplant CMV-specific T-cell immune reconstitution in the absence of global T-cell immunity is associated with a high risk of subsequent virus reactivation
- (2014) S-K Tey et al. BONE MARROW TRANSPLANTATION
- Relationship between cytomegalovirus (CMV) reactivation, CMV-driven immunity, overall immune recovery and graft-versus-leukaemia effect in children
- (2014) Mohamed Jeljeli et al. BRITISH JOURNAL OF HAEMATOLOGY
- The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?
- (2014) Mark R Wills et al. Cellular & Molecular Immunology
- Donor Cytomegalovirus Status Influences the Outcome of Allogeneic Stem Cell Transplant: A Study by the European Group for Blood and Marrow Transplantation
- (2014) Per Ljungman et al. CLINICAL INFECTIOUS DISEASES
- Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation
- (2014) R. Itzykson et al. HAEMATOLOGICA
- Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
- (2014) V. D. Kheav et al. HAEMATOLOGICA
- Risk for CMV reactivation in children undergoing allogeneic hematopoietic stem cell transplantation
- (2014) Muna Qayed et al. PEDIATRIC BLOOD & CANCER
- Timing of CMV-specific effector memory T cells predicts viral replication and survival after allogeneic hematopoietic stem cell transplantation
- (2014) Ildefonso Espigado et al. TRANSPLANT INTERNATIONAL
- Modulation of dendritic cell functions by viral IL-10 encoded by human cytomegalovirus
- (2014) Selmir Avdic et al. Frontiers in Microbiology
- CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT
- (2013) M. Schmidt-Hieber et al. BLOOD
- CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia
- (2013) M. L. Green et al. BLOOD
- Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation
- (2013) E. Blyth et al. BLOOD
- CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML
- (2013) S Ito et al. BONE MARROW TRANSPLANTATION
- High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation
- (2013) Einat Shmueli et al. JOURNAL OF INFECTIOUS DISEASES
- Circulating Dendritic Cells Isolated from Healthy Seropositive Donors Are Sites of Human Cytomegalovirus Reactivation In Vivo
- (2013) M. B. Reeves et al. JOURNAL OF VIROLOGY
- γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia
- (2013) W Scheper et al. LEUKEMIA
- Clinical Assessment of Anti-Viral CD8+ T Cell Immune Monitoring Using QuantiFERON-CMV® Assay to Identify High Risk Allogeneic Hematopoietic Stem Cell Transplant Patients with CMV Infection Complications
- (2013) Siok-Keen Tey et al. PLoS One
- Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy
- (2012) Byung-Sik Cho et al. ANNALS OF HEMATOLOGY
- Large Granular Lymphocyte Expansion after Allogeneic Hematopoietic Stem Cell Transplant Is Associated with a Cytomegalovirus Reactivation and Shows an Indolent Outcome
- (2012) Sabine Nann-Rütti et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation
- (2012) Margaret L. Green et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients
- (2012) P Hiwarkar et al. BONE MARROW TRANSPLANTATION
- Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen
- (2012) B. Foley et al. JOURNAL OF IMMUNOLOGY
- Efficient Human Cytomegalovirus Reactivation Is Maturation Dependent in the Langerhans Dendritic Cell Lineage and Can Be Studied using a CD14+Experimental Latency Model
- (2012) Margaret M. Huang et al. JOURNAL OF VIROLOGY
- A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2012) Mohamed A Kharfan-Dabaja et al. LANCET INFECTIOUS DISEASES
- Monitoring of Human Cytomegalovirus and Virus-Specific T-Cell Response in Young Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
- (2012) Daniele Lilleri et al. PLoS One
- Sequential Anti-Cytomegalovirus Response Monitoring May Allow Prediction of Cytomegalovirus Reactivation after Allogeneic Stem Cell Transplantation
- (2012) Sylvia Borchers et al. PLoS One
- A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group
- (2012) B. George et al. Transplant Infectious Disease
- Risk Factors for Progression from Cytomegalovirus Viremia to Cytomegalovirus Disease after Allogeneic Hematopoietic Stem Cell Transplantation
- (2011) Ji Eun Jang et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients
- (2011) A. H. Elmaagacli et al. BLOOD
- Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function
- (2011) B. Foley et al. BLOOD
- Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8+ and CD4+ T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT
- (2011) N Tormo et al. BONE MARROW TRANSPLANTATION
- Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK Cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients
- (2011) Beatriz Muñoz-Cobo et al. JOURNAL OF MEDICAL VIROLOGY
- Inhibition of Inflammatory Interleukin-6 Activity via Extracellular Signal-Regulated Kinase-Mitogen-Activated Protein Kinase Signaling Antagonizes Human Cytomegalovirus Reactivation from Dendritic Cells
- (2011) M. B. Reeves et al. JOURNAL OF VIROLOGY
- Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation
- (2011) S. Borchers et al. Transplant Infectious Disease
- Evidence for a Bidirectional Relationship between Cytomegalovirus Replication and acute Graft-versus-Host Disease
- (2010) Nathan Cantoni et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study
- (2010) J. W. Gratama et al. BLOOD
- The role of V 2-negative T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation
- (2010) A. Knight et al. BLOOD
- Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT
- (2010) L Król et al. BONE MARROW TRANSPLANTATION
- Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation
- (2010) K. S. Peggs et al. CLINICAL INFECTIOUS DISEASES
- Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age
- (2010) E. Castermans et al. HAEMATOLOGICA
- Experimental human cytomegalovirus latency in CD14+ monocytes
- (2010) D. Hargett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection
- (2010) Michael J. Cannon et al. REVIEWS IN MEDICAL VIROLOGY
- Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy
- (2010) B. George et al. Transplant Infectious Disease
- The Effect of Single and Combined Activating Killer Immunoglobulin-like Receptor Genotypes on Cytomegalovirus Infection and Immunity after Hematopoietic Cell Transplantation
- (2009) John A. Zaia et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients
- (2009) W. Zhou et al. BLOOD
- How we treat cytomegalovirus in hematopoietic cell transplant recipients
- (2009) M. Boeckh et al. BLOOD
- The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor
- (2009) P. Scheinberg et al. BLOOD
- Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNγ CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients
- (2009) N Tormo et al. BONE MARROW TRANSPLANTATION
- Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals
- (2009) S. Chidrawar et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Cytomegalovirus‐Specific T Cell Immunotherapy Promotes Restoration of Durable Functional Antiviral Immunity following Allogeneic Stem Cell Transplantation
- (2009) Karl S. Peggs et al. CLINICAL INFECTIOUS DISEASES
- Human Cytomegalovirus–Specific T Cell Reconstitution in Young Patients Receiving T Cell–Depleted, Allogeneic Hematopoietic Stem Cell Transplantation
- (2009) Daniele Lilleri et al. JOURNAL OF INFECTIOUS DISEASES
- Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT
- (2008) B Pourgheysari et al. BONE MARROW TRANSPLANTATION
- Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT
- (2008) P Ljungman et al. BONE MARROW TRANSPLANTATION
- Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations
- (2008) Jan W. Gratama et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection
- (2008) D. Lilleri et al. HAEMATOLOGICA
- Immunoglobulin Prophylaxis in Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis
- (2008) Pia Raanani et al. JOURNAL OF CLINICAL ONCOLOGY
- Patterns of Cytomegalovirus Reactivation Are Associated with Distinct Evolutive Profiles of Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
- (2008) Hélène Moins‐Teisserenc et al. JOURNAL OF INFECTIOUS DISEASES
- Expansion of Human Cytomegalovirus (HCMV) Immediate-Early 1-Specific CD8+ T Cells and Control of HCMV Replication after Allogeneic Stem Cell Transplantation
- (2008) K. Sacre et al. JOURNAL OF VIROLOGY
- Cytomegalovirusinfection in children who underwent hematopoietic stem cell transplantation at a single center: A retrospective study of the risk factors
- (2008) Hoi Soo Yoon et al. PEDIATRIC TRANSPLANTATION
- Levels of CMV Specific CD4 T Cells Are Dynamic and Correlate with CMV Viremia after Allogeneic Stem Cell Transplantation
- (2008) Thomas Widmann et al. PLoS One
- Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells
- (2007) Stephen Mackinnon et al. BLOOD CELLS MOLECULES AND DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now